|
"tu st"的相關文件
顯示項目 1-14 / 14 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2024-04-27 |
Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the diabetes association of the republic of China (Taiwan) and the Taiwanese association of diabetes educators
|
Shen, FC;Chu, CH;Chen, JF;Kuo, CS;Hsu, CY;Lin, CH;Sheen, YJ;Su, SC;Tien, KJ;Lu, CH;Lee, CC;Yang, YS;Tu, ST;Chen, PT;Chen, CC;Chien, MN;Li, HY;Sheu, WH;Huang, CN;Wang, CY;Ou, HY |
| 國家衛生研究院 |
2023-03 |
TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes
|
Yu, ML;Wang, CY;Lee, MH;Ou, HY;Cheng, PN;Tu, ST;Huang, JF;Chen, JF;Hu, TH;Hsu, CC;Kao, JH;Chen, CJ;Lin, HC;Huang, CN |
| 中山醫學大學 |
2021 |
The dawn phenomenon in type 2 diabetes: its association with glucose excursions and changes after oral glucose-lowering drugs
|
Wang, JS; Lee, IT; Lee, WJ; Lin, SD; Su, SL; Tu, ST; Lin, SY; Sheu, WHH |
| 中山醫學大學 |
2020 |
Use and effectiveness of dapagliflozin in patients with type 2 diabetes mellitus: a multicenter retrospective study in Taiwan
|
Chen, JF; Peng, YS; Chen, CS; Tseng, CH; Chen, PC; Lee, TI; Lu, YC; Yang, YS; Lin, CL; Hung, YJ; Chen, ST; Lu, CH; Yang, CY; Chen, CC; Lee, CC; Hsiao, PJ; Jiang, JY; Tu, ST |
| 國家衛生研究院 |
2019-11 |
Accountability and utilization of diabetes care from 2005 to 2014 in Taiwan
|
Wang, CY;Wu, YL;Sheu, WH;Tu, ST;Hsu, CC;Tai, TY |
| 國家衛生研究院 |
2019-10-28 |
Effect of diabetes mellitus on risk of latent TB infection in a high TB incidence area: A community-based study in Taiwan
|
Lin, CH;Kuo, SC;Hsieh, MC;Ho, SY;Su, IJ;Lin, SH;Chi, CY;Su, SL;Liao, CY;Chen, YC;Hsu, SR;Huang, YC;Tseng, FC;Wang, SY;Dou, HY;Lin, SD;Lin, JS;Tu, ST;Yeh, YP |
| 國家衛生研究院 |
2019-08-03 |
2019 diabetes atlas: Achievements and challenges in diabetes care in Taiwan
|
Hsu, CC;Tu, ST;Sheu, WH |
| 國家衛生研究院 |
2019-07-24 |
Trends of mortality in diabetic patients in Taiwan: A nationwide survey in 2005-2014
|
Li, HY;Wu, YL;Tu, ST;Hwu, CM;Liu, JS;Chuang, LM |
| 國家衛生研究院 |
2019-06-25 |
Trends in antidiabetic medical treatment from 2005 to 2014 in Taiwan
|
Chu, CH;Hsu, CC;Lin, SY;Chuang, LM;Liu, JS;Tu, ST |
| 國家衛生研究院 |
2018-01 |
Is there a preferred stroke prevention strategy for diabetic patients with non-valvular Atrial Fibrillation? Comparing warfarin, dabigatran and rivaroxaban
|
Hsu, CC;Hsu, PF;Sung, SH;Tu, ST;Yu, BH;Huang, CJ;Cheng, HM |
| 國家衛生研究院 |
2015-08 |
Effects of high-dose phytoestrogens on circulating cellular microparticles and coagulation function in postmenopausal women
|
Cheng, WC;Lo, SC;Tsai, KS;Tu, ST;Wu, JS;Chang, CI;Chen, CL;Shaw, NS;Peng, HY;Wang, SY;Wu, CH;Jan, IS;Hsu, SC;Liu, CW;Lee, LN;Tai, TY |
| 國家衛生研究院 |
2012-05 |
The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study
|
Tai, TY;Tsai, KS;Tu, ST;Wu, JS;Chang, CI;Chen, CL;Shaw, NS;Peng, HY;Wang, SY;Wu, CH |
| 高雄醫學大學 |
2011 |
Apolipoprotein E Polymorphism and the Progression of Diabetic Nephropathy in Type 2 Diabetes
|
田凱仁;杜思德;周劍文;楊純宜;蕭政岳;辛錫璋;陳鴻鈞;謝明家 ; Tien KJ;Tu ST;Chou CW;Yang CY;Hsiao JY;Shin SJ;Chen HC;Hsieh MC |
| 高雄醫學大學 |
2008 |
Chronic kidney disease as a risk factor for coronary artery disease in Chinese with type 2 diabetes
|
謝明家;蕭政岳;田凱仁;章順仁;許世傑;陳鴻鈞;林綉茹;杜思德 ; Hsieh MC;Hsiao JY;Tien KJ;Chang SJ;Hsu SC;Liang HT;Chen HC;Lin SR;Tu ST |
顯示項目 1-14 / 14 (共1頁)
1
每頁顯示[10|25|50]項目
|
